FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients

Erin L. Symonds; Jean M. Winter

doi:10.1016/j.lanepe.2022.100528

FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients

Erin L. Symonds, Jean M. Winter

Research output: Contribution to journal › Comment/debate

2 Citations (Scopus)

48 Downloads (Pure)

Abstract

Colonoscopy has proven efficacy for detection of neoplasia and other clinically relevant disease states, which has led to a reduction in colorectal cancer (CRC) incidence and mortality.1 It is used around the world in different settings, including for screening of the general population, investigating the cause of a positive faecal occult blood test, and surveillance of patients at elevated risk of CRC. Colonoscopy is also used to investigate the cause of gastrointestinal symptoms or iron deficiency anaemia, both of which can indicate presence of CRC.2

Original language	English
Article number	100528
Number of pages	2
Journal	The Lancet Regional Health - Europe
Volume	23
DOIs	https://doi.org/10.1016/j.lanepe.2022.100528
Publication status	Published - Dec 2022

Keywords

Colonoscopy
colorectal cancer (CRC)
faecal immunochemical test (FIT)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.lanepe.2022.100528Licence: CC BY-NC-ND

Final published versionFinal published version, 86.1 KBLicence: CC BY-NC-ND

Cite this

@article{6aa631cc3194410d843882c16de7390b,

title = "FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients",

abstract = "Colonoscopy has proven efficacy for detection of neoplasia and other clinically relevant disease states, which has led to a reduction in colorectal cancer (CRC) incidence and mortality.1 It is used around the world in different settings, including for screening of the general population, investigating the cause of a positive faecal occult blood test, and surveillance of patients at elevated risk of CRC. Colonoscopy is also used to investigate the cause of gastrointestinal symptoms or iron deficiency anaemia, both of which can indicate presence of CRC.2",

keywords = "Colonoscopy, colorectal cancer (CRC), faecal immunochemical test (FIT)",

author = "Symonds, {Erin L.} and Winter, {Jean M.}",

year = "2022",

month = dec,

doi = "10.1016/j.lanepe.2022.100528",

language = "English",

volume = "23",

journal = "The Lancet Regional Health - Europe",

issn = "2666-7762",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - FIT for colonoscopy

T2 - Benefits of the faecal immunochemical test for triaging symptomatic patients

AU - Symonds, Erin L.

AU - Winter, Jean M.

PY - 2022/12

Y1 - 2022/12

N2 - Colonoscopy has proven efficacy for detection of neoplasia and other clinically relevant disease states, which has led to a reduction in colorectal cancer (CRC) incidence and mortality.1 It is used around the world in different settings, including for screening of the general population, investigating the cause of a positive faecal occult blood test, and surveillance of patients at elevated risk of CRC. Colonoscopy is also used to investigate the cause of gastrointestinal symptoms or iron deficiency anaemia, both of which can indicate presence of CRC.2

AB - Colonoscopy has proven efficacy for detection of neoplasia and other clinically relevant disease states, which has led to a reduction in colorectal cancer (CRC) incidence and mortality.1 It is used around the world in different settings, including for screening of the general population, investigating the cause of a positive faecal occult blood test, and surveillance of patients at elevated risk of CRC. Colonoscopy is also used to investigate the cause of gastrointestinal symptoms or iron deficiency anaemia, both of which can indicate presence of CRC.2

KW - Colonoscopy

KW - colorectal cancer (CRC)

KW - faecal immunochemical test (FIT)

UR - http://www.scopus.com/inward/record.url?scp=85139730557&partnerID=8YFLogxK

U2 - 10.1016/j.lanepe.2022.100528

DO - 10.1016/j.lanepe.2022.100528

M3 - Comment/debate

AN - SCOPUS:85139730557

SN - 2666-7762

VL - 23

JO - The Lancet Regional Health - Europe

JF - The Lancet Regional Health - Europe

M1 - 100528

ER -

FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this